BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10602487)

  • 1. Expression of the SRF gene occurs through a Ras/Sp/SRF-mediated-mechanism in response to serum growth signals.
    Spencer JA; Misra RP
    Oncogene; 1999 Dec; 18(51):7319-27. PubMed ID: 10602487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic fibroblast growth factor activates serum response factor gene expression by multiple distinct signaling mechanisms.
    Spencer JA; Major ML; Misra RP
    Mol Cell Biol; 1999 Jun; 19(6):3977-88. PubMed ID: 10330138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Spemann organizer-expressed zinc finger gene Xegr-1 responds to the MAP kinase/Ets-SRF signal transduction pathway.
    Panitz F; Krain B; Hollemann T; Nordheim A; Pieler T
    EMBO J; 1998 Aug; 17(15):4414-25. PubMed ID: 9687509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression and activity of the immediate-early growth response (Egr-1) gene product during cellular senescence.
    Meyyappan M; Wheaton K; Riabowol KT
    J Cell Physiol; 1999 Apr; 179(1):29-39. PubMed ID: 10082129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression.
    Wang Z; Wang DZ; Hockemeyer D; McAnally J; Nordheim A; Olson EN
    Nature; 2004 Mar; 428(6979):185-9. PubMed ID: 15014501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the Tax interaction region of serum response factor that mediates the aberrant induction of immediate early genes through CArG boxes by HTLV-I Tax.
    Fujii M; Chuhjo T; Minamino T; Masaaki N; Miyamoto K; Seiki M
    Oncogene; 1995 Jul; 11(1):7-14. PubMed ID: 7624133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exendin-4 induction of Egr-1 expression in INS-1 beta-cells: interaction of SRF, not YY1, with SRE site of rat Egr-1 promoter.
    Kim MJ; Kang JH; Chang SY; Jang HJ; Ryu GR; Ko SH; Jeong IK; Kim MS; Jo YH
    J Cell Biochem; 2008 Aug; 104(6):2261-71. PubMed ID: 18446785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CrkII induces serum response factor activation and cellular transformation through its function in Rho activation.
    Iwahara T; Akagi T; Shishido T; Hanafusa H
    Oncogene; 2003 Sep; 22(38):5946-57. PubMed ID: 12955073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Egr-1, SRF, and Sp1 mRNA expression in contracting skeletal muscle cells.
    Irrcher I; Hood DA
    J Appl Physiol (1985); 2004 Dec; 97(6):2207-13. PubMed ID: 15310743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the serum response factor gene is regulated by serum response factor binding sites.
    Spencer JA; Misra RP
    J Biol Chem; 1996 Jul; 271(28):16535-43. PubMed ID: 8663310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of serum response factor to cystic fibrosis transmembrane conductance regulator CArG-like elements, as a new potential CFTR transcriptional regulation pathway.
    René C; Taulan M; Iral F; Doudement J; L'Honoré A; Gerbon C; Demaille J; Claustres M; Romey MC
    Nucleic Acids Res; 2005; 33(16):5271-90. PubMed ID: 16170155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of serum response factor and myocardin to transcriptional regulation of smoothelins.
    Rensen SS; Niessen PM; Long X; Doevendans PA; Miano JM; van Eys GJ
    Cardiovasc Res; 2006 Apr; 70(1):136-45. PubMed ID: 16451796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GTPase deficient mutant of G(alpha13) regulates the expression of Egr-1 through the small GTPase Rho.
    Vara Prasad MV; Dhanasekaran N
    Oncogene; 1999 Feb; 18(8):1639-42. PubMed ID: 10102635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the c-fos SRE through SAP-1a.
    Masutani H; Magnaghi-Jaulin L; Ait-Si-Ali S; Groisman R; Robin P; Harel-Bellan A
    Oncogene; 1997 Oct; 15(14):1661-9. PubMed ID: 9349499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The serum response factor (SRF) is needed for muscle-specific activation of CArG boxes.
    Soulez M; Tuil D; Kahn A; Gilgenkrantz H
    Biochem Biophys Res Commun; 1996 Feb; 219(2):418-22. PubMed ID: 8605002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transformation blocks differentiation-induced inhibition of serum response factor interactions with serum response elements.
    Ding W; Witte MM; Scott RE
    Cancer Res; 1999 Aug; 59(15):3795-802. PubMed ID: 10446998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc finger transcription factor Egr-1 is involved in stimulation of NHE2 gene expression by phorbol 12-myristate 13-acetate.
    Malakooti J; Sandoval R; Memark VC; Dudeja PK; Ramaswamy K
    Am J Physiol Gastrointest Liver Physiol; 2005 Oct; 289(4):G653-63. PubMed ID: 15976391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of a ternary SAP-1/SRF/c-fos SRE DNA complex.
    Mo Y; Ho W; Johnston K; Marmorstein R
    J Mol Biol; 2001 Nov; 314(3):495-506. PubMed ID: 11846562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smooth muscle expression of lipoma preferred partner is mediated by an alternative intronic promoter that is regulated by serum response factor/myocardin.
    Petit MM; Lindskog H; Larsson E; Wasteson P; Athley E; Breuer S; Angstenberger M; Hertfelder D; Mattsson E; Nordheim A; Nelander S; Lindahl P
    Circ Res; 2008 Jul; 103(1):61-9. PubMed ID: 18511849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.